- Markets
- Healthcare
- PHARMAID
PHARMAID
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Pharmaids Pharmaceuticals Receives Draft Letter Of Offer For Open Offer
Jan 10 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
PHARMAIDS PHARMACEUTICALS LTD - RECEIVES DRAFT LETTER OF OFFER FOR OPEN OFFER
PHARMAIDS PHARMACEUTICALS - OPEN OFFER TO ACQUIRE 9.2 MILLION SHARES AT 62.15 RUPEES PER SHARE
PHARMAIDS PHARMACEUTICALS - TOTAL DEAL VALUE OF OPEN OFFER 569.9 MILLION RUPEES
Source text: ID:nBSE12kNSP
Further company coverage: PPHM.BO
(([email protected];;))
Jan 10 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
PHARMAIDS PHARMACEUTICALS LTD - RECEIVES DRAFT LETTER OF OFFER FOR OPEN OFFER
PHARMAIDS PHARMACEUTICALS - OPEN OFFER TO ACQUIRE 9.2 MILLION SHARES AT 62.15 RUPEES PER SHARE
PHARMAIDS PHARMACEUTICALS - TOTAL DEAL VALUE OF OPEN OFFER 569.9 MILLION RUPEES
Source text: ID:nBSE12kNSP
Further company coverage: PPHM.BO
(([email protected];;))
Pharmaids Pharmaceuticals Unit Gets National Good Laboratory Practice Certification
Dec 9 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
UNIT GETS NATIONAL GOOD LABORATORY PRACTICE CERTIFICATION
Source text: ID:nBSE17r1Qr
Further company coverage: PPHM.BO
(([email protected];))
Dec 9 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
UNIT GETS NATIONAL GOOD LABORATORY PRACTICE CERTIFICATION
Source text: ID:nBSE17r1Qr
Further company coverage: PPHM.BO
(([email protected];))
Pharmaids Pharmaceuticals Acquires Additional Stake In Anugraha Chemicals
Oct 30 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
ACQUIRED ADDITIONAL STAKE IN ANUGRAHA CHEMICALS
DEAL FOR 80.9 MILLION RUPEES
Source text: ID:nBSE3vZn9L
Further company coverage: PPHM.BO
(([email protected];;))
Oct 30 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
ACQUIRED ADDITIONAL STAKE IN ANUGRAHA CHEMICALS
DEAL FOR 80.9 MILLION RUPEES
Source text: ID:nBSE3vZn9L
Further company coverage: PPHM.BO
(([email protected];;))
Pharmaids Pharmaceuticals Enters Into Loan Agreement To Avail Loan Of Up To 50 Mln Rupees
Sept 13 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
ENTERS INTO LOAN AGREEMENT TO AVAIL LOAN OF UP TO 50 MILLION RUPEES
Source text for Eikon: ID:nBSE1Msv3L
Further company coverage: PPHM.BO
(Reporting by VijayDattaram Malkar)
(([email protected];))
Sept 13 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
ENTERS INTO LOAN AGREEMENT TO AVAIL LOAN OF UP TO 50 MILLION RUPEES
Source text for Eikon: ID:nBSE1Msv3L
Further company coverage: PPHM.BO
(Reporting by VijayDattaram Malkar)
(([email protected];))
Pharmaids Pharmaceuticals Enters Agreement To Avail Loan Of 50 Million Rupees From Adita Bio Sys
July 11 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
PHARMAIDS PHARMACEUTICALS - ENTERED AGREEMENT TO AVAIL LOAN OF 50 MILLION RUPEES FROM ADITA BIO SYS
Source text for Eikon: ID:nBSE3sQ9mc
Further company coverage: PPHM.BO
(([email protected];))
July 11 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
PHARMAIDS PHARMACEUTICALS - ENTERED AGREEMENT TO AVAIL LOAN OF 50 MILLION RUPEES FROM ADITA BIO SYS
Source text for Eikon: ID:nBSE3sQ9mc
Further company coverage: PPHM.BO
(([email protected];))
Pharmaids Pharmaceuticals Additionally Acquired 9.35% Of Partnership Interest In Anugraha Chemicals
Feb 15 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
- ADDITIONALLY ACQUIRED 9.35% OF PARTNERSHIP INTEREST IN ANUGRAHA CHEMICALS
Source text for Eikon: ID:nBSE5Jtrc4
Further company coverage: PPHM.BO
(([email protected];))
Feb 15 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
- ADDITIONALLY ACQUIRED 9.35% OF PARTNERSHIP INTEREST IN ANUGRAHA CHEMICALS
Source text for Eikon: ID:nBSE5Jtrc4
Further company coverage: PPHM.BO
(([email protected];))
Pharmaids Pharmaceuticals To Invest 165 Million Rupees In Anugraha Chemicals, A Partnership Firm
Feb 12 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
PHARMAIDS PHARMACEUTICALS LTD - TO CONSIDER INVESTMENT OF 165 MILLION RUPEES IN ANUGRAHA CHEMICALS, A PARTNERSHIP FIRM
PHARMAIDS PHARMACEUTICALS LTD - APPROVED TO PURCHASE 4034.00 SQ.MTRS. OF LAND 51 MILLION RUPEES
Source text for Eikon: ID:nBSE9jCpVJ
Further company coverage: PPHM.BO
(([email protected];;))
Feb 12 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
PHARMAIDS PHARMACEUTICALS LTD - TO CONSIDER INVESTMENT OF 165 MILLION RUPEES IN ANUGRAHA CHEMICALS, A PARTNERSHIP FIRM
PHARMAIDS PHARMACEUTICALS LTD - APPROVED TO PURCHASE 4034.00 SQ.MTRS. OF LAND 51 MILLION RUPEES
Source text for Eikon: ID:nBSE9jCpVJ
Further company coverage: PPHM.BO
(([email protected];;))
Pharmaids Pharmaceuticals Approved Purchase Of Up To 3.7 Million Shares Of Adita Bio Sys
Jan 9 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
APPROVED PURCHASE OF UP TO 3.7 MILLION SHARES OF ADITA BIO SYS
Source text for Eikon: ID:nBSE9h6Wfl
Further company coverage: PPHM.BO
(([email protected];))
Jan 9 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
APPROVED PURCHASE OF UP TO 3.7 MILLION SHARES OF ADITA BIO SYS
Source text for Eikon: ID:nBSE9h6Wfl
Further company coverage: PPHM.BO
(([email protected];))
Pharmaids Pharmaceuticals To Consider Issuance Of Equity Shares Of Company
Jan 3 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
TO CONSIDER ISSUANCE OF EQUITY SHARES OF COMPANY ON PREFERENTIAL ISSUE BASIS
Source text for Eikon: ID:nBSE88RMYC
Further company coverage: PPHM.BO
(([email protected];))
Jan 3 (Reuters) - Pharmaids Pharmaceuticals Ltd PPHM.BO:
TO CONSIDER ISSUANCE OF EQUITY SHARES OF COMPANY ON PREFERENTIAL ISSUE BASIS
Source text for Eikon: ID:nBSE88RMYC
Further company coverage: PPHM.BO
(([email protected];))
Pharmaids Pharmacuticals Approves Acquisition Of 2 Industrial Land Parcels
May 22 (Reuters) - Pharmaids Pharmacuticals Ltd PPHM.BO:
APPROVED ACQUISITION OF 2 INDUSTRIAL LAND PARCELS
LAND MEANT TO SET UP PHARMACEUTICALS, BIOPHARMA, CONTRACT RESEARCH, MANUFACTURING SERVICES FACILITIES
Source text for Eikon: ID:nBSE5ttBqW
Further company coverage: PPHM.BO
(([email protected];))
May 22 (Reuters) - Pharmaids Pharmacuticals Ltd PPHM.BO:
APPROVED ACQUISITION OF 2 INDUSTRIAL LAND PARCELS
LAND MEANT TO SET UP PHARMACEUTICALS, BIOPHARMA, CONTRACT RESEARCH, MANUFACTURING SERVICES FACILITIES
Source text for Eikon: ID:nBSE5ttBqW
Further company coverage: PPHM.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Pharmaids Pharma do?
Pharmaids Pharmaceuticals Ltd, founded in 1991 in Hyderabad, Andhra Pradesh, specializes in manufacturing herbal cough syrups, cold tablets, pain reliever tablets, active charcoal tablets, joint pain ointments, and more.
Who are the competitors of Pharmaids Pharma?
Pharmaids Pharma major competitors are Sat Kartar Shopping, Alpa Lab, Natural Capsules, Coral Laboratories, Kimia Biosciences, Panchsheel Organics, Quest Laboratories. Market Cap of Pharmaids Pharma is ₹235 Crs. While the median market cap of its peers are ₹230 Crs.
Is Pharmaids Pharma financially stable compared to its competitors?
Pharmaids Pharma seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Pharmaids Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Pharmaids Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Pharmaids Pharma allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery
How strong is Pharmaids Pharma balance sheet?
Balance sheet of Pharmaids Pharma is strong. But short term working capital might become an issue for this company.
Is the profitablity of Pharmaids Pharma improving?
No, profit is decreasing. The profit of Pharmaids Pharma is -₹15.03 Crs for TTM, -₹7.97 Crs for Mar 2024 and -₹7.56 Crs for Mar 2023.
Is the debt of Pharmaids Pharma increasing or decreasing?
Yes, The debt of Pharmaids Pharma is increasing. Latest debt of Pharmaids Pharma is ₹7.58 Crs as of Sep-24. This is greater than Mar-24 when it was -₹4.23 Crs.
Is Pharmaids Pharma stock expensive?
Pharmaids Pharma is not expensive. Latest PE of Pharmaids Pharma is 0.0, while 3 year average PE is 45.15. Also latest EV/EBITDA of Pharmaids Pharma is 0.0 while 3yr average is 67.56.
Has the share price of Pharmaids Pharma grown faster than its competition?
Pharmaids Pharma has given better returns compared to its competitors. Pharmaids Pharma has grown at ~43.05% over the last 8yrs while peers have grown at a median rate of 11.31%
Is the promoter bullish about Pharmaids Pharma?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Pharmaids Pharma is 5.22% and last quarter promoter holding is 5.22%.
Are mutual funds buying/selling Pharmaids Pharma?
There is Insufficient data to gauge this.